Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic The limited effectiveness of current therapies against Alzheimer’s disease (AD) highlights the need for intensifying research efforts devoted to developing new agents for preventing or retarding the disease process. During the last few years, targeting the endogenous cannabinoid system has emerged as a potential therapeutic approach to treat Alzheimer. The endocannabinoid system is composed by … Continue reading Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic